Skip to main content
MarketsReportedMediumDeveloping
5.0

BASF CEO warns against exorbitant price for Evonik, tempers takeover expectations

BASF's CEO Kamieth signals reluctance to overpay for Evonik, tempering takeover speculation after a recent offer increase. The company raised its 2026 EBITDA forecast, indicating confidence in standalone growth. The outcome of M&A talks remains uncertain, with implications for chemical sector consolidation.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works

FDabout 19 hours agoDECredibility 28%View source

Score Breakdown

Mosaic Score5.0
Model confidence0.5
Significance0.5
Source credibility0.3

Intelligence Tags

Entities

Germanycountry
Source

Related signals

8 found